

Fundamental dimension Equity attribute | BKSCLeader $18.85▲+0.37% Cap $100.6MP/E 11.6x QuantScore74/100 | AUBNPeer $26.86▲+1.51% Cap $93.59MP/E 11.1x QuantScore60/100 | CCNBPeer $18.200.00% Cap $137.2MP/E 10.2x QuantScore66/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
73/100 |
69/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 100/100 | 100/100 |
Health Piotroski, Altman Z, leverage & liquidity | 33/100 | 33/100 | 22/100 |
Growth Revenue / earnings growth & margins | 69/100 | 35/100 | 73/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 11.6x | 11.1x | 10.2x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 4.4x | 6.0x | -6.0x |
Price / Sales | 3.3x | 2.5x | 2.2x |
Price / Free Cash Flow | 6.5x | 9.0x | — |
PEG ratio | 0.74 | 0.43 | 0.76 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 6 / 9 | 3 / 9 |
Altman Z-Score | 0.43 (Distress) | 0.30 (Distress) | 0.43 (Distress) |
Total debt / equity | 0.18 | 0.00 | 0.20 |
Quick ratio | — | — | — |
Interest coverage | 2.8x | 1.0x | 0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +35.4% | -22.3% | +14.5% |
Net income growth YoY | +17.1% | +13.4% | +28.5% |
Gross margin (TTM) | 85.1% | 91.8% | 67.8% |
Operating margin (FY) | 33.3% | 28.1% | 21.3% |
FCF margin (FY) | 50.8% | 33.1% | 15.9% |
5. Trailing price performancePrice change over period |
1M return | -0.3% | -1.4% | -1.2% |
3M return | +6.8% | +0.9% | +8.7% |
6M return | +17.9% | +11.9% | +27.7% |
Year to date | +19.7% | -0.3% | +40.2% |
1Y return | +19.2% | -0.5% | +44.7% |
3Y return | +75.0% | +23.4% | +96.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $42.41 +125.0% upside | $47.85 +78.2% upside | $51.48 +182.9% upside |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |